Acquired haemophilia A: Successful treatment with immunosuppression, methylprednisolone pulses and oral cyclosporin

Thrombosis and Haemostasis

Volumn 95, Issue 4, 2006, Pages 735-737

  Pardos Gea, José ^a   Ordi Ros, José ^a   Altisent, Carmen ^a   Balada, Eva ^a   Pérez López, Jorge ^a   Vilardell, Miguel ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8 INHIBITOR; CYCLOSPORIN A; METHYLPREDNISOLONE; PREDNISONE; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ADULT; AGED; ARTICLE; BRAIN DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; DRUG PULSE THERAPY; FEMALE; FOLLOW UP; HEMATOLOGY; HEMOPHILIA A; HEMOSTASIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MAINTENANCE THERAPY; MALE; PATIENT MONITORING; PRIORITY JOURNAL; RADIOIMMUNOASSAY; REMISSION; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS; CYCLOSPORINE; DRUG THERAPY, COMBINATION; FACTOR VIII; FEMALE; HEMOPHILIA A; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; METHYLPREDNISOLONE; MIDDLE AGED; PROSPECTIVE STUDIES; REMISSION INDUCTION; TREATMENT OUTCOME;

EID: 33645749797     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH04-12-0827     Document Type: Article

References (25)

1. Green D, Lechner K. A survey of 215 non-haemophilic patients with inhibitors to factor III. Thromb Haemost 1981; 45: 200-3.
2. Hauser I, Schneider B, Lechner K. Postpartum factor VIII inhibitors. Thromb Haemost 1995; 73: 1-5.
3. Sallah S, Wan JY. Inhibitors against Factor VIII in patients with cancer. Analysis of 41 patients. Cancer 2001; 91: 1067-74.
4. Pruthi RK, Nochols WL. Autoimmune factor VIII inhibitors. Curr Op Hematol 1999; 6: 314-22.
5. Kasper CK, Aledort LM, Aronson D, et al. Proceedings : A more uniform measurement of factor VIII inhibitors. Thromb Diath Haemorrh 1975; 34: 612.
6. Lottenberg R, Kentro TB, Kitchens CS. Acquired haemophilia: A natural study on 16 patients with factor VIII inhibitors receiving little or no therapy. Arch Inter Med 1987; 147: 1077-81.
7. Hay CR, Negrier C, Ludlam CA. The treatment of bleeding in acquired haemophilia with recombinant factor VIIa: a multicenter study. Thromb Haemost 1997; 78: 1463-7.
8. Delgado J, Jimenez-Yuste V, Hernández-Navarro F, et al. Acquired haemophilia: Review and meta-analysis focused on therapy and prognostic factors. Br J Haematol 2003; 121: 21-35.
9. Hart HC, Kraijenhagen RJ, Kerckhaert JAM, et al. A patient with spontaneous factor VIII:C autoanti-body:successful treatment with cyclosporine. Transplant Proc 1988; 20 (Suppl 4): 323-8.
10. Pflieger G, Boda Z, Harsfalvi J, et al. Cyclosporine treatment of a woman with acquired haemophilia due to factor VIII:C inhibitor. Postgrad Med J 1989; 65: 400-2.
11. Siegbahn A, Feltelius N, Norlen BJ, et al. Treatment of acquired haemophilia due to FVIII:C auto antibodies with recombinant FVIIa and cyclosporin. Thromb Haemost 1995; 73: 1424.
12. McLeod BC, McKenna R, Chediak J. Treatment of acquired factor VIII inhibitors with antibody removal by aphresis followed by immunosuppression with prednisone and cyclosporine. Blood 1989; 74: 39.
13. Shulman S, Langevithz P, Livneh A, et al. Cyclosporin therapy for acquired factor VIII inhibitor in a patient with systemic lupus erythematosus. Thromb Haemost 1996; 76: 344-6.
14. Brox AG, Laryea H, Pelletier M. Successful treatment of acquired factor VIII inhibitors with cyclosporin. Am J Hematol 1998; 57: 87-8.
15. Petrovic M, Derom E, Baele G. Cyclosporine treatment of acquired haemophilia due to factor VIII antibodies. Haematologica 2000; 85: 895-6.
16. Saxena R, Mishra DK, Kashyap R, et al. Acquired haemophilia-a study of ten cases. Haemophilia 2000; 6: 78-83.
17. Sueiras M, Gonzalez N, Rovira R, et al. Usefulness of the EEG recording in the diagnosis of cyclosporin A- induced encephalopathy. Rev Neurol 1998; 26: 766-9.
18. Pruthi RK, Nickols WL. Autoinmune factor VIII inhibitors. Curr Opin Hematol 1999; 6: 314-22.
19. Green D, Rademaker AW, Briet E. A randomised trial of prednisone and cyclophosphamide in the treatment of patients with factor VIII auto antibodies. Thromb Heamost 1993; 70: 753-7.
20. Spero JA, Lewis JH, Hasiba U. Corticosteroid therapy for acquired FBI:C inhibitors. Br J Haematol 1981; 48: 635-42.
21. Bossi P, Cabane J, Ninet J, et al. Acquired haemophilia due to factor VIII inhibitors in 34 patients. Am J Med 1998; 105: 400-8.
22. Schwart R, Gabriel DA, Alerdort LM, et al. A prospective study of treatment of acquired (autoimmune) factor VIII inhibitors with high-dose intravenous gamma globulin. Blood 1995; 86: 797-804.
23. Schwerdtfeger R, Hintz G, Huhn D. Successful treatment of a patient with postpartum factor VIII inhibitors with recombinant human interferon a2. Am J Hematol 1991; 37: 190-3.
24. Slocombe GW, Newland AC, Colvin MP, et al. The role of intensive plasma exchange in the prevention and management of haemorrhage in patients with inhibitors to factor VIII. Br J Haematol 1981; 47: 577-85.
25. Stasi R, Brunetti M, Stipa E, et al. Selective B-cell depletion with rituximab for the treatment of patients with acquired haemophilia. Blood 2004; 103: 4424-8.